We are live on ! Find out more
CCM

CAAS Capital Management Portfolio holdings

AUM $934M
1-Year Est. Return 1.45%
This Fund
S&P 500
This Quarter Est. Return
-15.25%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
–
AUM
$2B
AUM Growth
-$429M
Cap. Flow
-$22.8M
Cap. Flow %
-1.14%
Top 10 Hldgs %
16.55%
Holding
1,066
New
438
Increased
127
Reduced
103
Closed
189

Top Buys

Rank Stock Value
1
RIVN icon
Rivian
RIVN
+$44.9M
2
WBD icon
Warner Bros
WBD
+$41.2M
3
SLB icon
SLB Ltd
SLB
+$25.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$23M
5
TWTR
Twitter, Inc.
TWTR
+$22.8M

Top Sells

Rank Stock Value
1
ARWR icon
Arrowhead Research
ARWR
+$22.3M
2
TNET icon
TriNet
TNET
+$19.7M
3
SCHW
Charles Schwab
SCHW
+$17.8M
4
ADI icon
Analog Devices
ADI
+$15M
5
APLS
Apellis Pharmaceuticals
APLS
+$12.7M

Sector Composition

Rank Sector Weight
1 Financials 7.56%
2 Communication Services 4.58%
3 Technology 4.34%
4 Consumer Discretionary 3.67%
5 Energy 3.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTAQW
776
DELISTED
Carney Technology Acquisition Corp. II Warrant
CTAQW
$15K ﹤0.01%
96,700
– –
CFG icon
777
CALL
Citizens Financial Group
CFG
$30.3B
$14K ﹤0.01%
+400
New +$15.8K
SCLEW
778
DELISTED
Broadscale Acquisition Corp. Warrant
SCLEW
$14K ﹤0.01%
59,572
– –
ASBPW
779
Aspire Biopharma Warrant
ASBPW
$447K
$13K ﹤0.01%
+75,000
New +$16.3K
JWSM.WS
780
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$11K ﹤0.01%
+43,725
New +$18.6K
PIAI.WS
781
DELISTED
Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PIAI.WS
$11K ﹤0.01%
+173,100
New +$30K
BOAS.WS
782
DELISTED
BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share
BOAS.WS
$11K ﹤0.01%
66,600
– –
THCPW
783
DELISTED
Thunder Bridge Capital Partners IV, Inc. Warrant
THCPW
$10K ﹤0.01%
41,919
– –
ZLSWW
784
DELISTED
Zalatoris II Acquisition Corp Warrant
ZLSWW
$10K ﹤0.01%
+66,528
New +$17.7K
AGGRW
785
DELISTED
Agile Growth Corp Warrant
AGGRW
$10K ﹤0.01%
+48,305
New +$11.1K
LGACW
786
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$10K ﹤0.01%
+40,000
New +$15.3K
AUS.WS
787
DELISTED
Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
AUS.WS
$10K ﹤0.01%
+37,500
New +$14.2K
SPWRW
788
SunPower Inc Warrants
SPWRW
$746K
$9K ﹤0.01%
+37,500
New +$9.86K
MSDAW
789
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
$9K ﹤0.01%
+23,717
New +$11.9K
VEEAW
790
Veea Inc Warrant
VEEAW
$8K ﹤0.01%
+41,868
New +$13.6K
AONCW
791
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$8K ﹤0.01%
30,675
– –
IPVIW
792
DELISTED
InterPrivate IV InfraTech Partners Inc. Warrant
IPVIW
$8K ﹤0.01%
33,600
– –
PIPP.WS
793
DELISTED
Pine Island Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
PIPP.WS
$8K ﹤0.01%
26,900
– –
HHLA.WS
794
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$6K ﹤0.01%
+32,500
New +$6.38K
CPUH.WS
795
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$6K ﹤0.01%
25,000
– –
AFAQW
796
DELISTED
AF Acquisition Corp Warrants
AFAQW
$6K ﹤0.01%
45,424
– –
FACA.WS
797
DELISTED
Figure Acquisition Corp. I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
FACA.WS
$6K ﹤0.01%
31,250
– –
GGMCW
798
DELISTED
Glenfarne Merger Corp. Warrant
GGMCW
$6K ﹤0.01%
35,837
– –
TSPQ.WS
799
DELISTED
TCW Special Purpose Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TSPQ.WS
$6K ﹤0.01%
27,828
– –
LUXAW
800
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
$6K ﹤0.01%
43,200
– –
30 31
32
33 34

Similar funds

CIG
CCM Investment Group Northfield, Minnesota $946M AUM
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
SWC
Spectrum Wealth Counsel Indianapolis, Indiana $833M AUM 10.83% 1-Year Est. Return
KTA
Keeley-Teton Advisors Chicago, Illinois $825M AUM 5.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return

CAAS Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, CAAS Capital Management held 1,066 positions worth $2B, down 18% from $2.43B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

CAAS Capital Management's Q2 2022 filing shows 438 new, 127 increased, 103 reduced and 189 closed positions. Its largest new stake was Rivian: 1,438,628 shares worth $37M. The largest sale was Arrowhead Research, an estimated $22.3M.

By sector, the portfolio is most concentrated in Financials at 7.6% of assets, up from 5.5% a quarter earlier, followed by Communication Services and Technology.

  • CAAS Capital Management's largest Q2 2022 buy was Rivian: 1,438,628 shares worth $37M.
  • CAAS Capital Management added most to Twitter, Inc. in Q2 2022, an estimated $22.8M increase.
  • CAAS Capital Management's biggest Q2 2022 reduction was Arcellx, cutting an estimated $3.53M.
  • CAAS Capital Management fully exited Arrowhead Research in Q2 2022, selling an estimated $22.3M.
  • CAAS Capital Management's ten largest holdings make up 17% of its $2B portfolio in Q2 2022.
  • CAAS Capital Management opened 438 new positions and closed 189 in Q2 2022.
  • CAAS Capital Management's portfolio value fell 18% quarter-over-quarter to $2B.

Based on CAAS Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.